Suchergebnisse - "LY2940680"

PubPharm (12)

1

A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors

enthalten in: Investigational new drugs | 2021

von Azaro, A. | Massard, C. | Tap, W. | +9

2

A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors

enthalten in: Investigational new drugs | 2018

von Ueno, H. | Kondo, S. | Yoshikawa, S. | +4

3

Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Bendell, J. | Andre, V. | Ho, A. | +8

4

A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors

enthalten in: Investigational new drugs | 2018

von Ueno, H. | Kondo, S. | Yoshikawa, S. | +4

5

A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors

enthalten in: Investigational new drugs | 2018

von Ueno, H. | Kondo, S. | Yoshikawa, S. | +4

6

A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors

enthalten in: Investigational new drugs | 2018

von Ueno, H. | Kondo, S. | Yoshikawa, S. | +4

7

Development of taladegib as a sonic hedgehog signaling pathway inhibitor

enthalten in: Archives of pharmacal research | 2017

von Jin, G. | Sivaraman, A. | Lee, K.

8

Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden : a review of the literature with focus on a new generation of targeted therapies

enthalten in: International journal of dermatology | 2016

von Rudnick, E. | Thareja, S. | Cherpelis, B.

9

Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents : A Study on Primary Cell Cultures

enthalten in: PloS one | 2015

von Fraveto, A. | Cardinale, V. | Bragazzi, M. | +13

10

Molecular modeling study on the dynamical structural features of human smoothened receptor and binding mechanism of antagonist LY2940680 by metadynamics simulation and free energy calculation

enthalten in: Biochimica et biophysica acta | 2014

von Bai, Q. | Shen, Y. | Jin, N. | +2